U.S. Markets closed

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
16.60-0.08 (-0.48%)
At close: 4:00PM EDT

16.99 +0.39 (2.35%)
After hours: 6:09PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue146,691135,05775,334
Cost of Revenue33,20629,24522,732
Gross Profit113,485105,81252,602
Operating Expenses
Research Development150,84293,23679,696
Selling General and Administrative45,85340,02835,942
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-83,210-27,452-63,036
Income from Continuing Operations
Total Other Income/Expenses Net1,326422242
Earnings Before Interest and Taxes-81,884-27,030-62,794
Interest Expense19,9775,2015,581
Income Before Tax-101,861-32,231-68,375
Income Tax Expense1,162--
Minority Interest---
Net Income From Continuing Ops-103,023-32,231-68,375
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-103,023-32,231-68,375
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-103,023-32,231-68,375